ClinicalTrials.Veeva

Menu

Improving Cardiac Secondary Prevention

W

Western University, Canada

Status

Active, not recruiting

Conditions

Myocardial Infarction
Secondary Prevention

Treatments

Behavioral: Education regarding telomere length

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether providing individuals with personalized information on cellular aging, including telomere length, will stimulate them to adhere to cardiac prevention strategies and improve exercise capacity.

Full description

Individuals who have sustained a heart attack are at considerable risk for future cardiac events. A cardiac rehabilitation and exercise program can reduce this risk but it remains a challenge to adopt optimum lifestyle changes. We will determine whether providing individuals with information on leukocyte telomere length, will motivate them to improve their exercise performance. We will test whether professionally conveying this information will stimulate an individual to adhere to proven cardiac prevention strategies, looking at the extent to which one's exercise capacity improves over time.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Individuals who have sustained a myocardial infarction and entered the cardiac rehabilitation program

Exclusion criteria

  1. Individuals with genetic mutations that affect telomere length
  2. Individuals who may not have the mental capacity to understanding the ramifications of risk biomarkers

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Control
No Intervention group
Description:
Participants receive standard care in cardiac rehabilitation program
Knowledge transfer group
Experimental group
Description:
Participants receive standard care in cardiac rehabilitation program plus education regarding telomere length
Treatment:
Behavioral: Education regarding telomere length

Trial contacts and locations

1

Loading...

Central trial contact

Tim Hartley, MSc; J. Geoffrey Pickering, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems